A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Clinical trial NCT05970510 · COMPLETED
Trial details
- NCT number
- NCT05970510
- Sponsor
- Luye Pharma Group Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-04
- Primary completion
- 2025-07-31
- Enrollment
- 555
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.